ILiAD Biotechnologies
Weston, US · Founded 2026 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
KR
Keith RubinExecutive Officer, Director
WS
William SteinkraussExecutive Officer
KS
KEN SOLOVAYExecutive Officer
EE
Eric EdidinDirector
AN
Avi NaiderDirector
MB
Mario BarroDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$115.5MraisedFeb 2026 · 36 investors · BiotechnologyRule 506(b)
▶$115.5MraisedFeb 2026 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William SteinkraussExecutive Officer
- Avi NaiderDirector
- Mario BarroDirector
- Eric EdidinDirector
- Keith RubinExecutive Officer, Director
- Offering amount
- $115.5M
- Amount sold
- $115.5M
- Sales commissions
- $1.1M
- Proceeds to insiders
- $208.2K
- Placement agents
- Walter C. Greenblatt & Associates
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
▶$3MraisedOct 2022 · 43 investors · BiotechnologyRule 506(b)
▶$3MraisedOct 2022 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric EdidinDirector
- Corey HorowitzDirector
- Bin YanDirector
- Ken SolovayExecutive Officer
- David JohnstonExecutive Officer
- Avi NaiderDirector
- Keith RubinExecutive Officer, Director
- Ariel Pablos-MendezDirector
- Cuong DoDirector
- Offering amount
- $3M
- Amount sold
- $3M
- Sales commissions
- $28.3K
- Placement agents
- Walter C. Greenblatt & Associates
- First sale
- Oct 2022
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$42.8MraisedSep 2022 · 42 investors · BiotechnologyRule 506(b)
▶$42.8MraisedSep 2022 · 42 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ken SolovayExecutive Officer
- David JohnstonExecutive Officer
- Ariel Pablos-MendezDirector
- Keith RubinExecutive Officer, Director
- Eric EdidinDirector
- Corey HorowitzDirector
- Bin YanDirector
- Cuong DoDirector
- Avi NaiderDirector
- Offering amount
- $42.8M
- Amount sold
- $42.8M
- Sales commissions
- $2.4M
- Proceeds to insiders
- $1.5M
- Placement agents
- Walter C. Greenblatt & Associates, Cabot Lodge Securities, LLC, Guggenheim Securities, LLC
- First sale
- Aug 2022
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$23.5MofferedMar 2021 · BiotechnologyRule 506(b)
▶$23.5MofferedMar 2021 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- KEITH RUBINExecutive Officer, Director
- KEN SOLOVAYExecutive Officer, Director
- CUONG DODirector
- BIN YANDirector
- COREY HOROWITZDirector
- ARIEL PABLOS-MENDEZDirector
- Offering amount
- $23.5M
- Sales commissions
- $630K
- Proceeds to insiders
- $1.4M
- Placement agents
- WALTER GREENBLATT & ASSOCIATES
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$4.3MraisedMar 2020 · 36 investors · BiotechnologyRule 506(b)
▶$4.3MraisedMar 2020 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ARIEL PABLOS-MENDEZDirector
- KEN SOLOVAYExecutive Officer
- CUONG DODirector
- KEITH RUBINExecutive Officer, Director
- COREY HOROWITZDirector
- BIN YANDirector
- Offering amount
- $4.8M
- Amount sold
- $4.3M
- Sales commissions
- $368K
- Proceeds to insiders
- $660K
- Placement agents
- WALTER GREENBLATT & ASSOCIATES
- First sale
- Nov 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$20MofferedMar 2019 · BiotechnologyRule 506(b)
▶$20MofferedMar 2019 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- KEITH RUBINExecutive Officer, Director
- KEN SOLOVAYExecutive Officer
- BIN YANDirector
- CUONG DODirector
- Offering amount
- $20M
- Sales commissions
- $1.3M
- Proceeds to insiders
- $1.8M
- Placement agents
- WALTER GREENBLATT & ASSOCIATES
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$550KraisedAug 2018 · 2 investors · BiotechnologyRule 506(b)
▶$550KraisedAug 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- CUONG DODirector
- KEN SOLOVAYExecutive Officer
- BIN YANDirector
- KEITH RUBINExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $550K
- Sales commissions
- $400K
- Proceeds to insiders
- $500K
- Placement agents
- WALTER GREENBLATT & ASSOCIATES
- First sale
- Jul 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$675.2KraisedFeb 2018 · 11 investors · BiotechnologyRule 506(b)
▶$675.2KraisedFeb 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- KEN SOLOVAYExecutive Officer
- KEITH RUBINExecutive Officer
- Offering amount
- $5M
- Amount sold
- $675.2K
- Sales commissions
- $33.8K
- Proceeds to insiders
- $100K
- Placement agents
- WALTER GREENBLATT & ASSOCIATES
- First sale
- Jan 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.